Investigation and development of Graptopetalum paraguayense and its active components as anti-liver fibrotic and anti-liver cancer drugs
博士 === 國立陽明大學 === 生物藥學研究所 === 103 === Hepatocellular carcinoma (HCC) is the fifth most common malignancy and the third most common cause of cancer-related death worldwide. Sorafenib is the only drug for patients with advanced-stage hepatocellular carcinoma (HCC) that has been shown to confer a survi...
Main Authors: | Wei-Hsiang Hsu, 許偉祥 |
---|---|
Other Authors: | Chi-Ying F. Huang |
Format: | Others |
Language: | en_US |
Published: |
2015
|
Online Access: | http://ndltd.ncl.edu.tw/handle/55956961946750233990 |
Similar Items
-
Evaluation of the medicinal herb Graptopetalum paraguayense as a treatment for liver cancer.
by: Wei-Hsiang Hsu, et al.
Published: (2015-01-01) -
Bioactive Components Isolated from the Leaves of Graptopetalum paraguayense
by: Mei-Chin Chiu, et al.
Published: (2012) -
Bioactive Components Isolated from the Stem of Graptopetalum paraguayense
by: Ya-Chun Chang, et al.
Published: (2011) -
Evaluation of health effects of Graptopetalum paraguayense
by: Shu-Li Lin, et al.
Published: (2007) -
<i>Graptopetalum paraguayense</i> Inhibits Liver Fibrosis by Blocking TGF-β Signaling In Vivo and In Vitro
by: Wei-Hsiang Hsu, et al.
Published: (2019-05-01)